All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): Dronabinol,Palmitoylethanolamide
Therapeutic Area: Psychiatry/Psychology Product Name: SCI-110
Highest Development Status: Phase II Product Type: Small molecule
Partner/Sponsor/Collaborator: SciSparc
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration February 10, 2021
Details:
SCI-110 is an innovative proprietary combination drug candidate, formulated to treat the symptoms related to diseases of the central nervous system.
Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace
